HOME >> BIOLOGY >> NEWS
Columbia team finds treatment that corrects cellular defect at the root of heart failure

NEW YORK - Researchers at Columbia University have shown for the first time that beta blockers - drugs used to treat cardiovascular disease - can correct a specific defect in failing hearts.

"Up until now we have been treating symptoms but not the cause of heart failure," says Dr. Andrew R. Marks, Clyde and Helen Wu Professor of Molecular Cardiology at Columbia University College of Physicians & Surgeons and principal investigator of the study. "Our research shows that we can treat the cause." Dr. Marks also serves as director of Columbia's Center for Molecular Cardiology and is professor of medicine and pharmacology. The findings will be published in the Dec. 4 issue of the journal Circulation.

Heart failure, the leading cause of death in the developed world, occurs when the heart is too weak to sustain proper circulation. Some patients in heart failure receive left-ventricular assist devices (LVADs), which are implanted in the chest to help pump the blood and give the patient's own heart a rest as he or she waits for a heart transplant. Patients in heart failure may also be given drugs to improve symptoms. But heart transplant is the only way to cure heart failure.

Dr. Marks' research demonstrates that defects in the calcium channel controlling heart muscle function occur in heart failure. The membrane surrounding a cell contains a small calcium channel stimulated by the electrical impulses driving heart rhythm. When stimulated, this calcium channel triggers another, larger calcium channel within the cell, called the ryanodine receptor, to release calcium ions. The rush of calcium ions then signals the heart muscle to contract powerfully. The ryanodine receptor sits at the surface of the sarcoplasmic reticulum, a sac containing calcium ions, and is the major gatekeeper for calcium ion release.

The more calcium released through the ryanodine receptor, the stronger the contraction of the heart. Dr. Marks and his colleagues have
'"/>

Contact: Annie Bayne
as862@columbia.edu
Columbia University Medical Center
11-Dec-2001


Page: 1 2 3

Related biology news :

1. Columbia research to examine gene influence on severity of peridontal disease, therapy response
2. Columbia, Stony Brook, Guidant to develop biological pacemaker based on gene & cell therapies
3. Worlds largest scientific society holds regional meeting in Columbia, Mo.
4. New Columbia Genomic Center of Excellence aims to speed genetic targeting of medicines
5. Columbia offers new ecology program in Dominican Republic
6. Columbia professor receives 2003 National Golden Apple for Teaching Excellence
7. Columbia investigators win 2003 Gairdner International Award for research
8. Gene newly identified by Columbia researchers may improve hair removal
9. Years of research, thought lead geologist to propose new supercontinent Columbia
10. ESA Corporate Award winner 2001: Weyerhaeuser Company Limited British Columbia Coastal Forest Project Team
11. Columbia receives NYSTAR grant - Brain imaging studies will accelerate medical science and create jobs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2019)... , ... November 20, 2019 , ... BioInformatics Inc., part ... science tools market, today announced the winners of the Life Science Industry Awards for ... the Life Science Industry Awards – Innovation: , Most Innovative New Product – Cell ...
(Date:11/19/2019)... ... November 19, 2019 , ... Diagenode, Inc., ... Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science ... offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital PCR technology, to help ...
(Date:11/19/2019)... ... ... Hosted at the Las Vegas Convention Center, and brought to you by ... of MJBiz business professionals in the world. With over 1,300 exhibitors from more than ... show quite like it. Atlantic Ultraviolet will exhibit at Booth C9217, showcasing its ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... N.C. (PRWEB) , ... December 03, 2019 , ... A ... studies have shown can reduce and even reverse fibrosis (scar tissue) buildup – also ... at Stanford University School of Medicine, was conducted on mice. , The tumor-destroying ...
(Date:11/22/2019)... ... November 22, 2019 , ... Modality Solutions, ... cold chain validation guide to meet and exceed increasingly stringent regulatory expectations ... biopharmaceutical industry leaders, the September 19, 2019 webinar was well received and ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies , ... Genedata Biologics® to streamline their R&D operations related to the ...
(Date:11/6/2019)... ... 2019 , ... Diversified Technologies, Inc. has introduced a PEF production ... to improve processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of ... yields by up to 50% and achieve up to an 80% reduction of drying ...
Breaking Biology Technology:
Cached News: